Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05758688 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Study acronym: PROPS GYN
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 9 words Site contacts updated at 1 of 3 sites Show 1 more changeShow less
    • Site contacts updated at 1 of 3 sites
  2. Primary completion pushed from May 2026 to Nov 2026 Completion pushed from Nov 2026 to Dec 2026v12 Show 1 more changeShow less
    • Completion pushed from Nov 2026 to Dec 2026
  3. Re-verified, no change to tracked fieldsv11
  4. Study sites: 2 to 3v10
  5. Study sites: 1 to 2v9
Show 7 earlier versionsHide 7 earlier versions
  1. Re-verified, no change to tracked fieldsv8
  2. Phase: Not applicable to Phase 2 Primary completion date: Sep 2025 to May 2026 · Completion date: Mar 2026 to Nov 2026 · Secondary endpoints: details revised at 3 of 3 entries · 4 morev7 Show 7 more changesShow less
    • Primary completion date: Sep 2025 to May 2026
    • Completion date: Mar 2026 to Nov 2026
    • Secondary endpoints: details revised at 3 of 3 entries
    • Study description shortened, about 83 words
    • Study site revised
    • Eligibility criteria expanded, about 5 words
    • Study title expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Nov 2023 to Nov 6, 2023v6 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 2023 to Nov 6, 2023
  4. Start date: Sep 2023 to Nov 2023v5
  5. Start date: Jun 2023 to Sep 2023v4
  6. Start date: Mar 2023 to Jun 2023v3
  7. Lead sponsor: University of Pennsylvania to Abramson Cancer Center at Penn Medicinev2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of acute clinician-reported gastrointestinal (GI) toxicity using WP PBS PRT in the definitive treatment of gynecologic cancers in the post-surgical, adjuvant setting.
Trial Details
NCT Number NCT05758688
Lead Sponsor Abramson Cancer Center at Penn Medicine
Conditions Cervical Cancer, Uterine Cancer, Endometrial Cancer
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov